c‑Myc-Targeting PROTAC Based on a TNA-DNA Bivalent Binder for Combination Therapy of Triple-Negative Breast Cancer - Li, Xintong; Zhang, Ze; Gao, Fangyan; Ma, Yuxuan; Wei, Dongying; Lu, Zhangwei; Chen, Siqi; Wang, Mengqi; Wang, Yueyao; Xu, Kun; Wang, Runtian; Xu, Feng; et al. (Journal of the American Chemical Society, 2023)
Keywords: Animals; Antineoplastic Agents - pharmacology; Antineoplastic Agents - therapeutic use; breast neoplasms; Cell Line, Tumor; Cell Proliferation; cyclin-dependent kinase; Disease Models, Animal; DNA; Genes, myc; Humans; Mice; nucleotide sequences; oligonucleotides; prognosis; proteolysis; therapeutics; Transcription Factors; Triple Negative Breast Neoplasms - pathology